At present, Novo Nordisk has developed injection preparations (Ozempic) and oral preparations (Rybelsus) for semaglutide: Ozempic (semaglutide, injection preparation): is a weekly subcutaneous injection preparation (0.5mg or 1mg), suitable for: (1) as an auxiliary means of diet adjustment and exercise to improve blood sugar control in adult patients with type 2 diabetes (2) It is used for adult patients with type 2 diabetes with cardiovascular disease (CVD) to reduce the risk of major adverse cardiovascular events (MACE, including cardiovascular death, non-fatal heart attack, and non-fatal stroke)
Active GLP-1 (7-36) amide Levels This means that GLP-1 (7-36) amide is present at low physiological concentrations, making accurate measurements extremely difficult, particularly in fasted subjects who already have low levels of active GLP-1 2
It means the evidence base is theoretical, anecdotal, and rooted in pharmacokinetic modeling rather than clinical outcomes data
While everyones chasing semaglutide, the real disruption might be what comes next
If you want to achieve an even skin tone, feel fresh, or make your natural look stand out more, this treatment is perfect for you
Alcohol increases the risk of pancreatitis by direct pancreatic inflammation and by promoting heavy drinking patterns in some people